{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-028710","form_type":"8-K","ticker":"INSM","cik":"0001104506","company_name":"INSMED Inc","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.301817+00:00","generated_at":"2026-06-01T06:27:36.508765+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"medium","headline":"Insmed to host commercial webinar on June 4 to discuss market outlook for ARIKAYCE, brensocatib, treprostinil palmitil","bullets":["Webinar at 8:00 a.m. ET on June 4, 2024, live via investor relations website.","Focus on three programs: ARIKAYCE (amikacin liposome inhalation), brensocatib, and treprostinil palmitil inhalation powder.","Slide presentation furnished as Exhibit 99.1 with title slide only; no specific financial data disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-028710","json":"https://secwatch.observer/filing/0001140361-24-028710.json","markdown":"https://secwatch.observer/filing/0001140361-24-028710.md","text":"https://secwatch.observer/filing/0001140361-24-028710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/0001140361-24-028710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/ef20030527_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:27:36.508765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}